Screener
Palvella Therapeutics PVLA Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Short-term investments | 55,459 | — |
| Prepaid expenses and other current assets | 1,378 | 1,005 |
| Total current assets | 263,231 | 58,987 |
| Operating lease right-of-use assets, net | 528 | 572 |
| Total assets | $263,759 | $59,559 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $5,443 | $4,595 |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's operating lease ROU assets?
- Palvella Therapeutics (PVLA) reported operating lease ROU assets of $528K in Q1 2026.
- What is the long-term trend for Palvella Therapeutics's operating lease ROU assets?
- Over 4 years (2020 to 2025), Palvella Therapeutics's operating lease ROU assets has grown at a -38.2% compound annual growth rate (CAGR), from $3.93M to $572K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Palvella Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude